Drug Trial Radar · NCT04442347
Phase 1b Study to Assess Safety, Tolerability, and Pharmacokinetics of ARCT-810 in Stable Adult Subjects With Ornithine Transcarbamylase Deficiency
Last checked: Nov 19, 2026Latest source record: Aug 2, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
16
Actual
Start
Nov 3, 2020
Primary completion
Aug 30, 2023
Study completion Apr 30, 2024
Sponsor
- Lead sponsor
- Arcturus Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jun 22, 2020
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Determine the safety, tolerability and pharmacokinetics of single doses of ARCT-810 in clinically stable patients (stable on standard of care treatment, e.g. diet ± ammonia scavengers) with ornithine transcarbamylase deficiency (OTCD).
Conditions
- Ornithine Transcarbamylase Deficiency
Interventions
ARCT-810Biological
ARCT-810 is an investigational medicinal product comprising Ornithine Transcarbamylase (OTC) mRNA formulated in a lipid nanoparticle (LNP) under development.
PlaceboOther
The placebo for this study is 0.9% sterile saline.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence, severity and dose-relationship of adverse events (AEs)Time frame: 4 weeks
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
University of Florida
Gainesville, Florida
M Health Fairview Masonic Children's Hospital
Minneapolis, Minnesota
The Mount Sinai Hospital
New York, New York
Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania
University of Texas Southwestern Medical Center at Dallas
Dallas, Texas
Baylor University
Waco, Texas
University of Utah
Salt Lake City, Utah
Children's Wisconsin - Milwaukee Hospital
Milwaukee, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.